Hepatitis C virus infection induced vasculitis.
Cryoglobulinemia are immune complexes that may induce systemic cryoglobulinemic vasculitis, a small-vessel vasculitis involving the skin, the joints, the peripheral nerve system, and the kidneys. During the last 15 years, progresses have been done after the discovery of the hepatitis C virus, the main cause of cryoglobulins. Main factors associated with cryoglobulin production are female gender, alcohol intake above 50 g/day, extensive liver fibrosis, and steatosis. Symptomatic cryoglobulins (i.e., vasculitis) are associated with older age, longer duration of infection, and main characteristics of cryoglobulin (type II, IgM kappa, high serum levels). The physiopathology is complex, and it involves humoral immunity, B- and T-cellular immunity but not the virus itself. Peg-Interféron alpha Ribavirine combination leads to a virological and clinical response of the vasculitis in about 70% of patients. In nonresponders, recent open series suggested the efficacy of Rituximab with a good response in up to 80% of patients but a relapse in 42% after 7 months after the last infusion. For future prospects and projects, new therapeutic strategies include a combination of best antiviral treatment with Peg-Interferon plus Ribavirin and Rituximab. Multicenter controlled trials are mandatory.
Cacoub
Patrice
P
Université Pierre et Marie Curie-Paris 6, CNRS, UMR 7087, Paris, France. patrice.cacoub@psl.aphp.fr
Saadoun
David
D
D000998:Antiviral Agents / Q000627:therapeutic use; D018771:Arthralgia / Q000209:etiology; D003449:Cryoglobulinemia / Q000209:etiology; D006526:Hepatitis C / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000209:etiology; D016393:Lymphoma, B-Cell / Q000209:etiology; D010523:Peripheral Nervous System Diseases / Q000209:etiology; D011693:Purpura / Q000209:etiology; D014657:Vasculitis / Q000209:etiology* / Q000628:therapy
D000998:Antiviral Agents; D007166:Immunosuppressive Agents